Complete liver workup
Conduct this analysis
Blood draws at our service locations in Quebec. A healthcare professional can also review your results with you.
Rapid-onset jaundice, severe abdominal pain in the right upper quadrant, confusion or altered consciousness associated with known liver disease, or signs of upper gastrointestinal bleeding (vomiting blood, black stools) are situations that may indicate acute liver failure or a serious complication requiring immediate medical evaluation.
Call 911 immediately
Panel components and reference values
Reference values may vary depending on the laboratory, sex and age. The ranges shown below correspond to the adult standards most commonly used in Quebec.
| Marker | Abbreviation | Usual values | Origine principale |
|---|---|---|---|
| Alanine aminotransferase | ALAT (ALT) | 7 to 56 U/L | Hepatocyte cytoplasm; specific marker of hepatocellular injury |
| Aspartate aminotransferase | ASAT (AST) | 10 to 40 U/L | Hepatocytes, cardiac and skeletal muscle, kidney; less specific to the liver than ALT |
| Phosphatase alcaline | PAL (ALP) | 44 to 147 U/L | Biliary epithelium, bone, intestine, placenta; marker of cholestasis or bone involvement |
| Gamma-glutamyl transferase | GGT | Men: 8 to 61 U/L; Women: 5 to 36 U/L | Hepatocytes and biliary epithelium; very sensitive to alcohol and enzyme inducers |
| Total bilirubin | Bili T | 3 to 21 µmol/L | Breakdown product of hemoglobin; transported to the liver for conjugation and biliary excretion |
| Conjugated (direct) bilirubin | Bili C | Less than 5 µmol/L | Water-soluble fraction, excreted in bile; elevated in biliary obstruction or hepatitis |
| Unconjugated (indirect) bilirubin | Bili NC | Less than 17 µmol/L | Albumin-bound fraction; elevated in hemolysis or Gilbert's syndrome |
| Serum albumin | Alb | 35 to 50 g/L | Synthesized exclusively by the liver; marker of long-term hepatic synthetic function |
| Prothrombin time | TP (RNI) | PT: 70 to 100%; INR: 0.8 to 1.2 | Reflects the synthesis of vitamin K-dependent clotting factors; falls rapidly in acute hepatocellular failure |
| Lactate dehydrogenase | LDH | 135 to 225 U/L | Ubiquitous enzyme; not very specific, but useful in certain contexts (hemolysis, massive hepatic necrosis) |
Laboratory patterns and their interpretation
Liver panel analysis relies on recognizing patterns of combined abnormalities, each pointing to a distinct diagnostic category.
| Profile | Anomalies dominantes | Common causes |
|---|---|---|
| Hepatocellular injury | Elevated ALT and AST, ALT predominant | Viral hepatitis (A, B, C, E), drug-induced or toxic hepatitis, non-alcoholic steatohepatitis (NASH), alcoholic hepatitis, autoimmune hepatitis |
| Hepatocellular injury with AST predominance | AST/ALT ratio greater than 2 | Alcoholic hepatitis (De Ritis ratio), concomitant muscle involvement (rhabdomyolysis, myocardial infarction) |
| Cholestasis | Elevated ALP and GGT, elevated conjugated bilirubin | Gallstones, cholangitis, primary biliary cirrhosis, drug-induced cholestasis, neoplasm of the bile ducts or pancreas |
| Jaundice with unconjugated bilirubin | Elevated indirect bilirubin, normal transaminases | Gilbert's syndrome (benign), hemolysis, Crigler-Najjar syndrome |
| Hepatocellular failure | Low albumin, low PT, elevated bilirubin | Advanced cirrhosis, acute liver failure, fulminant hepatitis |
| Isolated enzyme induction | Elevated GGT, other markers normal | Alcohol consumption, enzyme-inducing medications, obesity, type 2 diabetes |
Main causes of liver abnormalities
| Category | Examples |
|---|---|
| Virales | Hepatitis A, B, C, D, E; Epstein-Barr virus (mononucleosis); cytomegalovirus |
| Drug-induced and toxic | Acetaminophen (paracetamol) overdose, statins, anti-tuberculosis drugs, azole antifungals, NSAIDs, herbal medicine and unregulated supplements |
| Metabolic | Non-alcoholic fatty liver disease (NAFLD/MASLD), type 2 diabetes, obesity, dyslipidemia, metabolic syndrome |
| Alcooliques | Alcoholic steatosis, alcoholic hepatitis, alcoholic cirrhosis |
| Auto-immunes | Autoimmune hepatitis, primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC) |
| Genetic and metabolic | Hereditary hemochromatosis, Wilson's disease, alpha-1 antitrypsin deficiency |
| Vasculaires | Budd-Chiari syndrome, hepatic congestion in right-sided heart failure |
| Neoplastic | Hepatocellular carcinoma, liver metastases, cholangiocarcinoma |
| Obstructives | Common bile duct stones, biliary stricture, pancreatic cancer, extrinsic compression |
Diagnostic approach to an abnormal liver panel
An isolated or combined elevation of liver markers calls for a structured approach aimed at identifying the etiology before guiding management.
- Complete medical history: alcohol consumption, medications (including natural products), family history, risk factors for chronic diseases
- Characterizing the pattern: cytolysis, cholestasis, hepatocellular insufficiency or mixed pattern
- Viral serology: anti-HAV antibodies, HBsAg, anti-HBc, anti-HCV depending on the context
- Liver autoimmune panel: ANA, ASMA, anti-LKM1, anti-mitochondrial antibodies (AMA)
- Metabolic workup: fasting blood glucose, HbA1c, lipid panel, BMI
- Overload workup: ferritin, transferrin saturation (hemochromatosis); ceruloplasmin, serum copper (Wilson)
- Abdominal ultrasound: morphological assessment of the liver, bile ducts and gallbladder
- Liver elastography (Fibroscan) or non-invasive fibrosis score (FIB-4, APRI) if chronic fibrosis is suspected
- Referral to gastroenterology or hepatology if the abnormality is persistent, severe or of undetermined etiology
Situations requiring regular liver function monitoring
- Treatment with statins, anti-tuberculosis drugs, methotrexate, amiodarone or other medications with recognized hepatotoxic potential
- Chronic alcohol use or history of alcohol-related liver disease
- Chronic hepatitis B or C under antiviral treatment or follow-up
- Metabolic syndrome, obesity or type 2 diabetes with suspected NAFLD/MASLD
- Known liver cirrhosis, at any stage
- Family history of hemochromatosis, Wilson disease or hepatocellular carcinoma
- Preoperative assessment for major abdominal or hepatobiliary surgery
Consult at Clinique Omicron
A complete liver panel can be ordered and interpreted by Clinique Omicron physicians and nurse practitioners (IPS) as part of preventive medicine follow-up, an annual health check-up or a targeted investigation. Results are analyzed in light of the patient's overall clinical context in order to guide further investigations or referral to the appropriate specialty as needed. Book an appointment online or by phone at one of Clinique Omicron's points of service in Quebec.
The content of this page is provided for informational purposes only and is not intended to replace the advice of a qualified healthcare professional. Consult a physician for any symptoms, questions or decisions you may have regarding your health.
Omicron Clinic
Need to consult a doctor?
In-person or via telemedicine, anywhere in Quebec.
We accept insurance. Telemedicine consultations available 7 days a week. No family doctor required.